Caillé G, Larivière L, Lacasse Y, Vézina M, Besner J G
Biopharm Drug Dispos. 1986 Jan-Feb;7(1):63-9. doi: 10.1002/bdd.2510070109.
In order to examine a potential interaction between isoxicam and propranolol, single 200 mg doses of isoxicam were administered to ten healthy male volunteers before and during treatment with propranolol, gradually attaining a dose of 80 mg t.i.d. for 11 days. The pharmacokinetic profiles of the isoxicam plasma concentration/time data obtained over 96 h following the doses of isoxicam before and during propranolol administration were compared. No significant change was found in any of the pharmacokinetic parameters determined. These results suggest that propranolol has no effect on the metabolic disposition of isoxicam.
为了研究异恶酰胺与普萘洛尔之间的潜在相互作用,在普萘洛尔治疗前及治疗期间,给10名健康男性志愿者单次服用200 mg异恶酰胺,普萘洛尔逐渐增至80 mg,每日3次,共服用11天。比较了服用普萘洛尔前、后异恶酰胺剂量后96小时内获得的异恶酰胺血浆浓度/时间数据的药代动力学特征。所测定的任何药代动力学参数均未发现显著变化。这些结果表明,普萘洛尔对异恶酰胺的代谢处置没有影响。